GlassScriptPhysician profile
Caitlin Rae Claridge
NPI 1922503747
$401.94
in general payments reported to CMS, 2019-2025
11 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $95.69 · 2024: $204 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $97.33 | 2024 | Zurzuvae |
| Myriad Women'S Health, INC. | $65.59 | 2023 | Myrisk |
| Shield Therapeutics INC | $64.93 | 2024-2025 | |
| Baxter Healthcare | $49.03 | 2025 | Perclot |
| Applied Medical Resources Corporation | $43.73 | 2024 | |
| Roche Diagnostics Corporation | $18.55 | 2024 | |
| Astellas Pharma US INC | $18.46 | 2023 | Veozah |
| Coloplast Corp | $16.12 | 2025 | |
| Exeltis, USA INC. | $13.68 | 2024 | Slynd |
| Mayne Pharma Commercial LLC | $11.64 | 2023 | |
| Organon LLC | $2.88 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Claridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.